These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...
5d
New Scientist on MSNStrongest evidence yet that Ozempic and Wegovy reduce alcohol intakeThe drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results